Welcome MK4482-001 Study Investigators

This website is for obtaining informed consent from your patient who is eligible to participate in A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults with COVID-19.

Please navigate through this site to setup the Informed Consent Form for your patient prior to handing the device to the patient.